The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care
- 1 May 2001
- journal article
- research article
- Published by SAGE Publications in Vascular Medicine
- Vol. 6 (2) , 87-96
- https://doi.org/10.1177/1358836x0100600204
Abstract
The Minnesota Regional Peripheral Arterial Disease Screening Program was designed to define the efficacy of community PAD detection efforts, to assess the disease-specific and health-related morbidity, to assess PAD awareness rates, and to determine the magnitude of atherosclerosis disease risk factors and the intensity of their management. The target population was recruited via mass media efforts directed at individuals over 50 years of age and those with leg pain with ambulation. Screening sessions included assessments of the ankle-brachial index, blood pressure, fasting lipid profile, and use of validated tools to detect symptomatic claudication (by the Modified WHO-Edinburgh Claudication Questionnaire), walking impairment (Walking Impairment Questionnaire -WIQ), quality of life (MOS SF-36), PAD awareness, and the intensity of PAD medical therapeutic interventions. PAD was defined as any ankle-brachial index ≤0.85 or a history of lower extremity revascularization. The program evaluated 347 individuals and identified 92 subjects with PAD and 255 subjects without PAD, yielding a detection rate of 26.5%. Individuals with PAD were older, tended to have higher blood pressures, and had a significant walking impairment and an impaired health-related quality of life compared with the non-PAD subjects. Current rates of tobacco use were low. Lipid-lowering, estrogen replacement, anti-platelet, and antihypertensive medications and exercise therapies were underutilized in the PAD cohort. Peripheral arterial disease awareness was low in these community-identified patients. This Program demonstrated that individuals with PAD can be efficiently identified within the community, but that current standards of medical care are low. These data can assist in the future development of PAD awareness, education, and treatment programs.Keywords
This publication has 33 references indexed in Scilit:
- The Role of Tobacco Cessation, Antiplatelet and Lipid-Lowering Therapies in the Treatment of Peripheral Arterial DiseaseVascular Medicine, 1997
- Claudication as an ‘Orphan Disease’: Rationale and Goals of Drug Therapy for Peripheral Arterial DiseaseVascular Medicine, 1996
- Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.Circulation, 1993
- Mortality over a Period of 10 Years in Patients with Peripheral Arterial DiseaseNew England Journal of Medicine, 1992
- The ratio of ankle and arm arterial pressure as an independent predictor of mortalityAtherosclerosis, 1991
- Basic Data Related to the Natural History of Intermittent ClaudicationAnnals of Vascular Surgery, 1989
- Fate in intermittent claudication: outcome and risk factors.BMJ, 1986
- The prevalence of peripheral arterial disease in a defined population.Circulation, 1985
- Clinical Pharmacology of Pentoxifylline With Special Reference to Its Hemorrheologic Effect for the Treatment of Intermittent ClaudicationThe Journal of Clinical Pharmacology, 1985
- The fate of patients with intermittent claudication managed nonoperativelyThe American Journal of Surgery, 1976